Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 168

Similar articles for PubMed (Select 22350703)

1.

Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial.

Otsuka T, Kawazoe S, Nakashita S, Kamachi S, Oeda S, Sumida C, Akiyama T, Ario K, Fujimoto M, Tabuchi M, Noda T.

J Gastroenterol. 2012 Aug;47(8):912-7. doi: 10.1007/s00535-012-0554-7. Epub 2012 Feb 18.

PMID:
22350703
2.

Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.

Katsinelos P, Fasoulas K, Paroutoglou G, Chatzimavroudis G, Beltsis A, Terzoudis S, Katsinelos T, Dimou E, Zavos C, Kaltsa A, Kountouras J.

Endoscopy. 2012 Jan;44(1):53-9. doi: 10.1055/s-0031-1291440. Epub 2011 Dec 23.

PMID:
22198776
3.

A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.

Sethi S, Sethi N, Wadhwa V, Garud S, Brown A.

Pancreas. 2014 Mar;43(2):190-7. doi: 10.1097/MPA.0000000000000090. Review.

PMID:
24518496
4.

Can postendoscopic retrograde cholangiopancreatography pancreatitis be prevented by a pharmacological approach?

Cheon YK.

Korean J Intern Med. 2013 Mar;28(2):141-8. doi: 10.3904/kjim.2013.28.2.141. Epub 2013 Feb 27. Review.

5.

Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial.

Cheon YK, Cho KB, Watkins JL, McHenry L, Fogel EL, Sherman S, Schmidt S, Lazzell-Pannell L, Lehman GA.

Gastrointest Endosc. 2007 Dec;66(6):1126-32.

PMID:
18061712
6.

Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis.

Khoshbaten M, Khorram H, Madad L, Ehsani Ardakani MJ, Farzin H, Zali MR.

J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 2):e11-6. Epub 2007 Aug 7.

PMID:
17683501
7.

[Effect of the administration of rectal indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography, and its impact on the development of secondary pancreatitis episodes].

Montaño Loza A, Rodríguez Lomelí X, García Correa JE, Dávalos Cobián C, Cervantes Guevara G, Medrano Muñoz F, Fuentes Orozco C, González Ojeda A.

Rev Esp Enferm Dig. 2007 Jun;99(6):330-6. Spanish.

8.

[Effects of rectal indomethacin in the prevention of post-ERCP acute pancreatitis].

Döbrönte Z, Toldy E, Márk L, Sarang K, Lakner L.

Orv Hetil. 2012 Jun 24;153(25):990-6. doi: 10.1556/OH.2012.29403. Hungarian.

PMID:
22714033
9.

The effect of indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis.

Ahmad D, Lopez KT, Esmadi MA, Oroszi G, Matteson-Kome ML, Choudhary A, Bechtold ML.

Pancreas. 2014 Apr;43(3):338-42. doi: 10.1097/MPA.0000000000000086.

PMID:
24622061
10.

Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.

Li ZS, Pan X, Zhang WJ, Gong B, Zhi FC, Guo XG, Li PM, Fan ZN, Sun WS, Shen YZ, Ma SR, Xie WF, Chen MH, Li YQ.

Am J Gastroenterol. 2007 Jan;102(1):46-51.

PMID:
17266687
11.

Low-dose heparin for the prevention of post-ERCP pancreatitis: a randomized placebo-controlled trial.

Barkay O, Niv E, Santo E, Bruck R, Hallak A, Konikoff FM.

Surg Endosc. 2008 Sep;22(9):1971-6. doi: 10.1007/s00464-007-9738-2. Epub 2008 Jan 24.

PMID:
18214607
12.

Indomethacin for post-endoscopic retrograde cholangiopancreatography pancreatitis prophylaxis: is it the magic bullet?

Yang D, Draganov PV.

World J Gastroenterol. 2012 Aug 21;18(31):4082-5. doi: 10.3748/wjg.v18.i31.4082.

13.

A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis.

Elmunzer BJ, Waljee AK, Elta GH, Taylor JR, Fehmi SM, Higgins PD.

Gut. 2008 Sep;57(9):1262-7. doi: 10.1136/gut.2007.140756. Epub 2008 Mar 28. Review.

PMID:
18375470
14.

Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.

Choi CW, Kang DH, Kim GH, Eum JS, Lee SM, Song GA, Kim DU, Kim ID, Cho M.

Gastrointest Endosc. 2009 Apr;69(4):e11-8. doi: 10.1016/j.gie.2008.10.046.

PMID:
19327467
15.

Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography.

Murray B, Carter R, Imrie C, Evans S, O'Suilleabhain C.

Gastroenterology. 2003 Jun;124(7):1786-91.

PMID:
12806612
16.

25 mg versus 50 mg dose of rectal diclofenac for prevention of post-ERCP pancreatitis in Japanese patients: a retrospective study.

Yoshihara T, Horimoto M, Kitamura T, Osugi N, Ikezoe T, Kotani K, Sanada T, Higashi C, Yamaguchi D, Ota M, Mizuno T, Gotoh Y, Okuda Y, Suzuki K.

BMJ Open. 2015 Mar 20;5(3):e006950. doi: 10.1136/bmjopen-2014-006950.

17.

Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by epinephrine sprayed on the papilla.

Xu LH, Qian JB, Gu LG, Qiu JW, Ge ZM, Lu F, Wang YM, Li YM, Lu HS.

J Gastroenterol Hepatol. 2011 Jul;26(7):1139-44. doi: 10.1111/j.1440-1746.2011.06718.x.

PMID:
21392105
18.

Therapy: can rectal NSAIDs prevent post-ERCP pancreatitis?

Testoni PA.

Nat Rev Gastroenterol Hepatol. 2012 Aug;9(8):429-30. doi: 10.1038/nrgastro.2012.117. Epub 2012 Jun 19. No abstract available.

PMID:
22710572
19.

Can Rectal Diclofenac Prevent Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis?

Lua GW, Muthukaruppan R, Menon J.

Dig Dis Sci. 2015 Mar 11. [Epub ahead of print]

PMID:
25757446
20.

Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP.

Sotoudehmanesh R, Khatibian M, Kolahdoozan S, Ainechi S, Malboosbaf R, Nouraie M.

Am J Gastroenterol. 2007 May;102(5):978-83. Epub 2007 Mar 13.

PMID:
17355281
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk